Detalles de la búsqueda
1.
Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis.
Pain Med
; 24(3): 341-350, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36102822
2.
Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose.
J Clin Pharm Ther
; 46(6): 1505-1508, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34240442
3.
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent Formulation.
Pain Med
; 20(4): 747-757, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29608768
4.
Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
Pain Med
; 19(6): 1195-1205, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29897589
5.
Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users.
Pain Med
; 19(8): 1597-1612, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29016880
6.
Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users.
Pain Med
; 19(12): 2438-2449, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29092079
7.
Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.
Pain Med
; 19(1): 97-117, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29206984
8.
Risk Factors for Opioid-Use Disorder and Overdose.
Anesth Analg
; 125(5): 1741-1748, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29049118
9.
A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
Pain Med
; 18(12): 2350-2360, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28371937
10.
Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users.
Pain Med
; 18(1): 61-77, 2017 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27330154
11.
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users.
Pain Med
; 18(5): 898-907, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27633773
12.
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid Users.
Pain Med
; 18(9): 1695-1705, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27651510
13.
Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
Pain Med
; 18(8): 1496-1504, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28810695
14.
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Drug Liking Study on a Novel Abuse-Deterrent Formulation of Morphine-Morphine ARER.
Pain Med
; 18(7): 1303-1313, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27651506
15.
A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone.
Pain Med
; 17(6): 1112-30, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26814256
16.
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users.
Am J Drug Alcohol Abuse
; 42(5): 539-549, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27211522
17.
Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy.
Antimicrob Agents Chemother
; 59(1): 498-504, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25385094
18.
A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
Am J Gastroenterol
; 110(5): 725-32, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25916220
19.
Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review.
J Clin Gastroenterol
; 49(1): 9-16, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25356996
20.
Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.
Eur J Clin Pharmacol
; 71(3): 303-11, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25666027